{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:11:56Z","timestamp":1789711916587,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.vaccine.2025.127932","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:40:35Z","timestamp":1762033235000},"page":"127932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prioritization of future new vaccines introduction: The experience of the Ethiopian National Immunization Technical Advisory Group"],"prefix":"10.1016","volume":"68","author":[{"given":"Solomon Tessema","family":"Memirie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telahun","family":"Teka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amha","family":"Mekasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tewodros","family":"Alemayehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melkamu Ayalew","family":"Kokobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohannes Lakew","family":"Tefera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Workeabeba","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirgissa","family":"Kaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassor","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Guiod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Senouci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127932_bb0005","doi-asserted-by":"crossref","unstructured":"Li X, Mukandavire C, Cucunuba\u00b4 ZM, Londono SE, Abbas K, Clapham HE, et al. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. Lancet 2021; 397:398\u2013408. doi: https:\/\/doi.org\/10.1016\/S0140-6736(20)32657-X [PMID: 33516338].","DOI":"10.1016\/S0140-6736(20)32657-X"},{"key":"10.1016\/j.vaccine.2025.127932_bb0010","author":"WHO"},{"key":"10.1016\/j.vaccine.2025.127932_bb0015","article-title":"The World Bank","year":"2024","journal-title":"Data: Ethiopia"},{"key":"10.1016\/j.vaccine.2025.127932_bb0020","series-title":"National Implementation Guideline for Expanded Program on Immunization, Ministry of Health-Ethiopia","year":"2021"},{"key":"10.1016\/j.vaccine.2025.127932_bb0025","series-title":"Sixty-fifth world health Assembly: Geneva, 21\u201326 may 2012: Resolutions and decisions, annexes","author":"World Health Assembly, 65","year":"2012"},{"key":"10.1016\/j.vaccine.2025.127932_bb0030","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.127932_bb0035","author":"Institute of Health Metrics and Evaluation"},{"key":"10.1016\/j.vaccine.2025.127932_bb0040","series-title":"Ethiopia National Heath Accounts Report, 2019\/20","author":"Ministry of Health","year":"2022"},{"key":"10.1016\/j.vaccine.2025.127932_bb0045","author":"Gavi"},{"key":"10.1016\/j.vaccine.2025.127932_bb0050","series-title":"When Every Dollar Counts: Why Budget Execution Reform is Urgent for 37 Countries Facing US Aid Cuts. When Every Dollar Counts: Why Budget Execution Reform is Urgent for 37 Countries Facing US Aid Cuts | Center For Global Development","author":"Gupta","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127932_bb0055","series-title":"Radical Simplification: A Practical Way to Get More of Limited Foreign Assistance Budgets. Radical Simplification: A Practical Way to Get More Out of Limited Foreign Assistance Budgets | Center For Global Development","author":"Glennerster","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127932_bb0060","series-title":"Life-saving yellow fever vaccine approved for introduction into Ethiopia\u2019s routine immunization programme. Life-saving yellow fever vaccine approved for introduction into Ethiopia\u2019s routine immunization programme | WHO | Regional Office for Africa","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127932_bb0065","series-title":"Ethiopia Immunization Full Portfolio Planning 2023\u20132025: Application document submitted to Gavi","author":"Ministry of Health","year":"2022"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127932_bb0070","first-page":"13","article-title":"The Ethiopian National Immunization Technical Advisory Group (E-NITAG): establishment, achievements and the future","volume":"34","author":"Berhane","year":"2024","journal-title":"Ethiop J Health Sci"},{"key":"10.1016\/j.vaccine.2025.127932_bb0075","series-title":"Weekly epidemiologic record Meeting of the Strategic Advisory Group of Experts on Immunization, March 2025: conclusion and recommendations","first-page":"219","volume":"23:100","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127932_bb0080","series-title":"Development Catalysts, JSI, IVAC and McKing Consulting Corporation. New vaccines\u2019 introduction prioritization and sequencing framework: Toolkit. New Vaccines\u2019 Introduction Prioritization and Sequencing Framework: Toolkit. Accessed May 9","author":"BMGF","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127932_bb0090","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(19)30721-4","article-title":"The pneumonia etiology research for child health (PERCH) study group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127932_bb0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijregi.2024.01.004","article-title":"Prevalence of respiratory syncytial virus infection and associated factors in children aged under five years with severe acute respiratory illness and influenza-like illness in Ethiopia","volume":"10","author":"Tayachew","year":"2024","journal-title":"IJID Regions"},{"key":"10.1016\/j.vaccine.2025.127932_bb0100","series-title":"Analysis hub. Ethiopia: Drivers of cholera outbreak thematic report","author":"ACAPS","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127932_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijid.2023.09.003","article-title":"Estimates of the global burden of congenital rubella syndrome, 1996-2019","volume":"137","author":"Vynnycky","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127932_bb0110","series-title":"Weekly Epidemiologic record. Rubella vaccines: WHO Position Paper \u2013 July","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.vaccine.2025.127932_bb0115","series-title":"Weekly Epidemiologic record. Diphtheria vaccines: WHO Position Paper \u2013 August","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.vaccine.2025.127932_bb0120","series-title":"Weekly epidemiologic record","volume":"vol. Number 40","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.vaccine.2025.127932_bb0125","series-title":"Weekly Epidemiologic record. Tetanus vaccines: WHO Position Paper \u2013 February","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.vaccine.2025.127932_bb0130","series-title":"Weekly Epidemiologic record, Number 39. Haemophilus influenzae type b (Hib) vaccination Position Paper \u2013 July","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.vaccine.2025.127932_bb0135","series-title":"Weekly Epidemiologic record. Hepatitis B vaccines: WHO Position Paper \u2013 July","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.vaccine.2025.127932_bb0140","series-title":"Weekly Epidemiologic record. Polio vaccines: WHO Position Paper \u2013 June","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.vaccine.2025.127932_bb0145","series-title":"Weekly Epidemiologic record. Meningococcal vaccines: WHO Position Paper on the use of multivalent meningococcal conjugate vaccines in countries of the African meningitis belt \u2013 January","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127932_bb0150","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent Prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127932_bb0155","series-title":"Weekly Epidemiologic record, Number 49. Meeting of the Strategic Advisory Group of Experts on Immunization, September 2024: conclusions and recommendations\u2013 December","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127932_bb0160","series-title":"Weekly epidemiologic record","volume":"vol. Number 13","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.vaccine.2025.127932_bb0165","series-title":"Weekly epidemiologic record","volume":"vol. Number 34","author":"World Health Organization","year":"2017"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127932_bb0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0000000000005817","article-title":"Preterm birth frequency and associated outcomes from the MATISSE (maternal immunization study for safety and efficacy) maternal trial of the bivalent respiratory syncytial virus Prefusion F protein vaccine","volume":"145","author":"Madhi","year":"2025","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127932_bb0175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4269\/ajtmh.14-0683","article-title":"A randomized, placebo-controlled trial evaluating safety and immunogenicity of the killed, bivalent, whole-cell Oral cholera vaccine in Ethiopia","volume":"93","author":"Desai","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2025.127932_bb0180","article-title":"Prevalence and antimicrobial susceptibility level of typhoid fever in Ethiopia: a systematic review and meta-analysis","volume":"25","author":"Teferi","year":"2022","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.vaccine.2025.127932_bb0185","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/S1473-3099(18)30124-5","article-title":"Mass chemoprophylaxis for control of outbreaks of meningococcal disease","volume":"18","author":"McNamara","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127932_bb0190","series-title":"Addis Ababa, Ethiopia, and Rockville, Maryland, USA: EPHI","article-title":"Ethiopia service provision assessment 2021\u201322 final report","author":"Ethiopian Public Health Institute (EPHI) [Ethiopia], Ministry of Health (MoH) [Ethiopia] and ICF","year":"2023"},{"key":"10.1016\/j.vaccine.2025.127932_bb0195","article-title":"Detailed product profiles (DPPs) for WHO prequalified vaccines","author":"Gavi","year":"2024","journal-title":"Gavi, the Vaccine Alliance"},{"key":"10.1016\/j.vaccine.2025.127932_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-084207","article-title":"Cost of delivering childhood RSV prevention interventions to the health system in Kenya: a prospective analysis","volume":"14","author":"Baral","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2025.127932_bb0205","unstructured":"Gavi, The vaccine Alliance. Ethiopia: Country information. https:\/\/www.gavi.org\/programmes-impact\/country-hub\/africa\/ethiopia. Accessed December 23, 2024."},{"key":"10.1016\/j.vaccine.2025.127932_bb0210","article-title":"United Nations: Department of Economic and Social Affairs Population Division. World population","year":"2024","journal-title":"Prospects"},{"key":"10.1016\/j.vaccine.2025.127932_bb0215","first-page":"8","article-title":"The Vaccine Alliance","author":"Gavi","year":"2024","journal-title":"Vaccine Funding guidelines"},{"key":"10.1016\/j.vaccine.2025.127932_bb0220","series-title":"The Market Information for Access Initiative (MI4A). Global vaccine market report 2024. January","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127932_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063059","article-title":"Estimating the health workforce requirements and costing to reach 70% COVID-19 vaccination coverage by mid-2022: a modelling study and global estimates","volume":"12","author":"Boniol","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2025.127932_bb0230","series-title":"Market information for access to vaccines (MI4A)","author":"World Health Organization","year":"2024"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:23:48Z","timestamp":1781663028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25012290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"alternative-id":["S0264410X25012290"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127932","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prioritization of future new vaccines introduction: The experience of the Ethiopian National Immunization Technical Advisory Group","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127932"}}